Electronic Health Records in Genomic Medicine

Genomic and Personalized Medicine

Volumn 1, Issue , 2013, Pages 287-294

  Gerhard, Glenn S ^a   Carey, David J ^a   Steele, Glenn D ^a  

^a WEIS CENTER FOR RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880562167     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382227-7.00024-0     Document Type: Chapter

References (17)

1. Facio F.M., Feero W.G., Linn A., Oden N., Manickam K., Biesecker L.G. Validation of My Family Health Portrait for six common heritable conditions. Genet Med 2010, 12:370-375.
2. FDA (2010). Table of Valid genomic biomarkers in the context of approved drug labels. <>. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ ucm083378.htm.
3. Feero W.G., Bigley M.B., Brinner K.M. New standards and enhanced utility for family health history information in the electronic health record: An update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc 2008, 15:723-728.
4. Giovanni M.A., Murray M.F. The application of computer-based tools in obtaining the genetic family history. Curr Protoc Hum Genet 2010, Chapter 9, Unit 9 21.
5. Glaser J., Henley D.E., Downing G., Brinner K.M. Advancing personalized health care through health information technology: An update from the American health information community's personalized health care workgroup. J Am Med Inform Assoc 2008, 15:391-396.
6. Hoffman M.A. The genome-enabled electronic medical record. J Biomed Inform 2007, 40:44-46.
7. Kuhn T.M., Barr M.S., Gardner L.A., Baker D.W. EHR-Based Quality Measurement and Reporting Critical for Meaningful Use and Health Care Improvement: A Position Paper of the American College of Physicians 2010, ACP Executive Committee Board of Regents, .
8. Li C., Schwarz U.I., Ritchie M.D., Roden D.M., Stein C.M., Kurnik D. Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood 2009, 113:3925-3930.
9. McDonnell C., Werner K., Wendel L. Electronic Health Record Usability: Vendor Practices and Perspectives 2010, Agency for Healthcare Research and Quality, Rockville, MD, AHRQ publication no. 09(10)-0091-3-EF.
10. Mega J.L., Close S.L., Wiviott S.D., et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009, 360:354-362.
11. Merril, M. March 2010. Product Spotlight: EHR market to change. In Healthcare IT News, p. 60.
12. Office of the National Coordinator of Health Information Technology The ONC-Coordinated Federal Health IT Strategic Plan: 2008-2012 2008, Department of Health and Human Services, Washington, D.C.
13. SACGHS Realizing the Potential of Pharmacogenomics: Opportunities and Challenges. Report of the Secretary's Advisory Committee on Genetics, Health, and Society 2008, Department of Health and Human Services, .
14. Sarkar I.N. Biomedical informatics and translational medicine. J Transl Med 2010, 8:22.
15. Sax U., Schmidt S. Integration of genomic data in electronic health records-opportunities and dilemmas. Methods Inf Med 2005, 44:546-550.
16. Shoor R., Flaherty M. First Successful Electronic Transfer of Genetic Data Runs on InterSystems Ensemble Technology 2010, InterSystems Corporation, .
17. Simon T., Verstuyft C., Mary-Krause M., et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009, 360:363-375.